5.27
price up icon1.74%   0.09
after-market Handel nachbörslich: 5.22 -0.05 -0.95%
loading

Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
43.86%
6.1835
4.2983 6.9617 6.9629 11.24
Interest Income/Expense
3.06%
0.4985
0.5143 0.5387 0.5271 0.4913
Operating Income/Loss
54.05%
-9.3939
-6.0978 -9.5504 -10.34 -16.80
Nonoperating Income/Loss
2.46%
1.3117
1.3448 1.3635 1.3557 1.1876
Income/Loss From Continuing Operations Before Tax
70.04%
-8.0821
-4.753 -8.1869 -8.987 -15.62
Income/Loss From Continuing Operations After Tax
70.04%
-8.0821
-4.753 -8.1869 -8.987 -15.62
Net Income/Loss
70.04%
-8.0821
-4.753 -8.1869 -8.987 -15.62
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
70,151%
59.41
0.0846 58.99 58.79 58.79
Diluted Average Shares
70,151%
59.41
0.0846 58.99 58.79 58.79
Basic Earnings Per Share
75.00%
-0.14
-0.08 -0.14 -0.15 -0.27
Diluted Earnings Per Share
75.00%
-0.14
-0.08 -0.14 -0.15 0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):